Precipio (PRPO) P/E (2011 - 2026)
Precipio (PRPO) P/E from Mar 31, 2011 to Jul 21, 2026. The TTM Precipio (PRPO) P/E is -46.53. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Precipio (PRPO)
| Year | P/E | Change |
|---|---|---|
| 2026 | -46.53 | -41.88% |
| 2025 | -80.06 | +4163.97% |
| 2024 | -1.88 | +110.98% |
| 2023 | -0.89 | -14.18% |
| 2022 | -1.04 | -74.35% |
| 2021 | -4.04 | +54.83% |
| 2020 | -2.61 | +169.26% |
| 2019 | -0.97 | +278.97% |
| 2018 | -0.26 | -86.38% |
| 2017 | -1.88 | +948.86% |
| 2016 | -0.18 | -62.74% |
| 2015 | -0.48 | -96.88% |
| 2014 | -15.42 | +336.96% |
| 2013 | -3.53 | -24.59% |
| 2012 | -4.68 | -26.11% |
| 2011 | -6.33 | N/A |
Comparison Precipio (PRPO) P/E with competitors
Precipio (PRPO) P/E is -46.53.
| Ticker | Name | P/E | Upside |
|---|---|---|---|
| ADVB | Advanced Biomed Inc | 1.05 | -102.25% |
| MBAI | CheckCap Ltd | 1.71 | -103.68% |
| FONR | Fonar Corp | 15.48 | -133.27% |
| QGEN | Qiagen NV | 20.03 | -143.05% |
| DGX | Quest Diagnostics Inc | 22.47 | -148.30% |
| LH | Laboratory Corp Of America Holdings | 23.87 | -151.30% |
| IQV | IQVIA Holdings Inc | 25.28 | -154.34% |
| A | Agilent Technologies Inc | 26.96 | -157.94% |
| TMO | Thermo Fisher Scientific Inc | 31.53 | -167.76% |
| MTD | Mettler-Toledo International Inc | 32.45 | -169.74% |
| MEDP | Medpace Holdings Inc | 32.55 | -169.96% |
| DHR | Danaher Corp | 38.55 | -182.86% |
| IDXX | Idexx Laboratories Inc | 40.58 | -187.21% |
| ILMN | Illumina Inc | 44.12 | -194.82% |
| RVTY | Revvity Inc | 52.68 | -213.22% |
| VCYT | Veracyte Inc | 53.71 | -215.44% |
| ICLR | Icon Plc | 57.45 | -223.48% |
| SHC | Sotera Health Company | 74.08 | -259.22% |
| WAT | Waters Corp | 102.79 | -320.91% |